Findings from the Hydra study
Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause Status, Age, or Other Hormone Levels | 0 | 14.55 | 04-08-2026 |
| 2 | Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy | 0 | 7.02 | 21-07-2026 |
| 3 | 'Teachable moment': AMA bolsters lung cancer screening guidance | 0 | 8.78 | 24-07-2026 |
| 4 | Detecting Glaucoma in Myopic Eyes With OCT | 0 | 7 | 02-07-2026 |
| 5 | Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia | 0 | 5.63 | 12-08-2026 |
| 6 | FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T Cells-vldq for Use in Matched Donor HSCT for Adult Patients with Haematologic Malignancies | 0 | 14.59 | 12-08-2026 |
| 7 | EMA Recommends Extension of Therapeutic Indications for Cetuximab | 0 | 11.3 | 14-08-2026 |
| 8 | Калужские онкологи получили патент на метод обследования | 0 | 13.57 | 15-08-2026 |
| 9 | Doctors question evidence behind Pentagon plan for testosterone screening | 0 | 5 | 20-07-2026 |
| 10 | Описана опасность пауэрбанков | 0 | 10 | 29-07-2026 |